Home » Topics » Regulatory » Patents

Patents
RSS

Guangzhou Maxinovel Pharmaceuticals discloses PD-1 signaling inhibitors

Jan. 29, 2018

Acquist patents novel SLC22A12 inhibitors

Jan. 29, 2018

Atea Pharmaceuticals patents new antiviral nucleotide derivatives

Jan. 26, 2018

Novel HIV maturation inhibitors described by ViiV Healthcare

Jan. 26, 2018

The University of California, Oakland divulges novel anticancer compounds

Jan. 26, 2018

New TGF-beta receptor type-1 inhibitors patented by Hanmi

Jan. 26, 2018

Boehringer Ingelheim identifies novel cytochrome P450 11B2 inhibtors

Jan. 26, 2018

Shanghai Institute of Cell Therapy and collaborators patent novel transgenic killer cells

Jan. 25, 2018

Nitto Denko identifies novel inhibitors of GST class-pi and MRP-L17

Jan. 25, 2018

Genetically modified HUCPVCs created at Tissue Regeneration Therapeutics

Jan. 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...